PUBLICATION NAME

Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia.

CEC // Clinical Trials Centre

Ranibizumab treatment for choroidal neovascularization from causes other than age-related macular degeneration and pathological myopia.

Carneiro A.M., Silva R., Veludo M.J., Barbosa A., Ruiz-Moreno J.M., Falcão M.S., Brandão E.M., Falcão-Reis F.M.

Ophthalmologica 2011;225(2):81-8

2011